SF3B1 and myelodysplastic syndrome: MDS with ring sideroblasts (MDS-RS) is characterized by bone marrow dysplasia, cytopenia, low risk of AML transformation, ring sideroblasts ≥15% of bone marrow precursors, and presence of SF3B1 mutation (6, 7).